BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Research Centre for Biomedical Engineering - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Research Centre for Biomedical Engineering
X-ORIGINAL-URL:https://creb.upc.edu
X-WR-CALDESC:Events for Research Centre for Biomedical Engineering
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20220309T100000
DTEND;TZID=UTC:20220309T120000
DTSTAMP:20260610T203031
CREATED:20220304T080955Z
LAST-MODIFIED:20220304T081107Z
UID:10085-1646820000-1646827200@creb.upc.edu
SUMMARY:SOCIETAT PANTALLA - SESSIÓ 2: Els nous divulgadors: informar o predicar?
DESCRIPTION:Qui i què es comunica avui dia? Com han canviat el big data i la intel·ligència artificial el periodisme i la comunicació? S’ha democratitzat la informació? El fet que tothom pugui ser divulgador i comunicador permet oferir més diversitat i qualitat en la informació? Quin és el negoci darrere de la generació d’aquests continguts que es pugen a les plataformes? Quina societat estem creant des del punt de vista informatiu?\nAmb Xantal Llavina (directora i presentadora de Revolució 4.0 a Catalunya Ràdio i TV3)\, Gemma Galdón (sociòloga i fundadora d’Eticas Research & Consulting) i Roc Massaguer (periodista i youtuber pioner @Outconsumer).
URL:https://creb.upc.edu/event/societat-pantalla-sessio-2-els-nous-divulgadors-informar-o-predicar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220310T120000
DTEND;TZID=UTC:20220310T140000
DTSTAMP:20260610T203031
CREATED:20220304T165207Z
LAST-MODIFIED:20220304T165333Z
UID:10095-1646913600-1646920800@creb.upc.edu
SUMMARY:Xartec Salut - TAULA RODONA - "Brain Drain in the spanish framework"
DESCRIPTION:Dins dels serveis d’innovació oferts per la Xartec Salut hi ha l’Observatori\, que pretén ser un catalitzador per a l’intercanvi de coneixement entre la xarxa\, l’ecosistema HealthTech i la societat. L’última publicació de l’Observatori (“Brain Drain on the Spanish Network“) té el propòsit d’analitzar les principals causes i l’impacte del fenomen de la fuga de talent i\, amb això\, convidar a la reflexió i al diàleg.\n\n\n\nEn aquest sentit i sobre aquest tema\, Xartec Salut conjuntament amb el CREB\, ha organitzat una taula rodona que té l’objectiu d’identificar línies de treball i propostes concretes des d’un punt de vista constructiu al voltant d’aquesta problemàtica.\n\n\n\n\n10 de març a l’Aula Capella de la UPC – ETSEIB (Avinguda Diagonal\, 647\, 08028 Barcelona)\, a les 12h00.
URL:https://creb.upc.edu/event/taula-rodona-brain-drain-in-the-spanish-framework/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220316T100000
DTEND;TZID=UTC:20220316T120000
DTSTAMP:20260610T203031
CREATED:20220304T081401Z
LAST-MODIFIED:20220304T081546Z
UID:10090-1647424800-1647432000@creb.upc.edu
SUMMARY:SOCIETAT PANTALLA – SESSIÓ 3: La construcció social des de darrera la pantalla
DESCRIPTION:Són les finalitats de les plataformes i les xarxes socials tan idealistes com defensen els seus fundadors? Quin ús tenen o poden tenir les nostres dades? Tenen fronteres\, les dades? Què desconeixem de les plataformes i les xarxes socials? Quins paràmetres se segueixen per a definir els algorismes? A qui afavoreixen?\nAmb Esther Paniagua (periodista i autora especialitzada en ciència i tecnologia)\, Nuria Oliver (directora de recerca en ciències de dades a Vodafone i del DataPop Alliance) i Karina Gibert (catedràtica i directora d’Intelligent Data Science & AI de la UPC).
URL:https://creb.upc.edu/event/societat-pantalla-sessio-3-la-construccio-social-des-de-darrera-la-pantalla/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220317T110000
DTEND;TZID=UTC:20220317T123000
DTSTAMP:20260610T203031
CREATED:20220311T161316Z
LAST-MODIFIED:20220315T095017Z
UID:10162-1647514800-1647520200@creb.upc.edu
SUMMARY:Xartec Salut - TRAINING PILL - How to obtain the CE Mark with Medical Devices: Introduction to the EU MDR 2017/745
DESCRIPTION:How to obtain the CE Mark with Medical Devices: Introduction to the EU MDR 2017/745 \n– Carmen Martín – \nBrief description of the session / register \nMedical technologies are the top technical field in patent applications in Europe since 2020. However\, only a small percentage of these patents obtain the CE Mark\, which is one of the most important milestones. European certification requires meticulous planning by the manufacturer from a regulatory perspective. In order to ensure that medical devices are safe\, this training lays the foundation for regulatory planning\, beginning with the classification of the device\, the EU regulatory ecosystem\, the conformity assessment procedure\, the clinical evaluation\, the development of the technical documentation\, and the requirements for quality management system certification and registration. \nCarmen Martín has a career of more than 25 years of experience in Regulatory Affairs\, Clinical Research and Quality Assurance\, working with the Medical Devices Industry. Carmen is an expert in ensuring that regulatory strategies are conducted effectively to meet business objectives and legal requirements as well as protect life and human health. Carmen has led over 200 internal and external audits as a lead auditor and technical product specialist for Medical Devices and In-Vitro Diagnostic devices as well as their manufacturers. Carmen is also a MedTech guest speaker in the start-up and university ecosystem.
URL:https://creb.upc.edu/event/xartec-salut-training-pill-how-to-obtain-the-ce-mark-with-medical-devices-introduction-to-the-eu-mdr-2017-745/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220331T110000
DTEND;TZID=UTC:20220331T123000
DTSTAMP:20260610T203031
CREATED:20220311T161847Z
LAST-MODIFIED:20220315T095104Z
UID:10165-1648724400-1648729800@creb.upc.edu
SUMMARY:Xartec Salut - TRAINING PILL - "Key points to successfully protect your inventions by patents\, copyright and know-how"
DESCRIPTION:“Key points to successfully protect your inventions by patents\, copyright and know-how”\n– Bernabé Zea – \nDescription of the session /register \nThis talk\, aimed especially at researchers\, will explain the steps to be taken to obtain adequate protection for inventions in order to facilitate the transfer of technology and\, ultimately\, its commercialization and monetization. \nFirst\, the different forms of protection (patents\, know-how and copyright) will be briefly described\, as well as the requirements for obtaining them. The concept of freedom to operate associated with the product or service to be commercialized will also be explained. \nThe difference between invention and commercial product will then be clarified. How it is possible to protect different aspects of the product through different patents\, or by using different forms of protection. How to extrapolate protection from concrete solutions found in the laboratory\, to broad inventions that can offer protection to a much more commercially interesting platform will also be covered. \nThere are certain discoveries that are not patentable. In addition\, in recent years the criteria for exceptions to patentability that exist in Europe and the USA have been separated and have become much more demanding in the USA\, especially in the area of diagnostics. What can and cannot be protected in both territories will be explained. \nSoftware\, an indispensable element in many medical devices\, will be given special consideration\, as it is patent-protectable under certain conditions\, but can also be protected by copyright. How to take advantage of this dual protection will be explained. Protection through know-how may sometimes be the best route to follow\, this too will be explained. \nIn the case of patents\, the different existing protection routes\, the times associated with protection and also the costs will be discussed. So that the researcher can adjust the protection to the timescale of their research. It will also be explained which experiments are necessary to achieve better protection\, so that the effectiveness of the experimental results can be maximized. \nFinally\, different examples will be used to facilitate the practical application of the course content covered. A compilation will be made of the key ideas that any researcher or innovation manager should know about the protection of inventions. \n  \nBernabé Zea is founding partner of ZBM Patents & Trademarks\, one of the most reputed Spanish patent firms. Bernabé has extensive experience in preparing patentability\, infringement and freedom-to- operate opinions\, negotiating patent licences\, conducting due diligence and drafting patents. His practice focuses on organic chemistry and pharmacy\, but also includes biotechnology and biochemistry. \nHe frequently acts as an expert in patent court actions before Spanish courts. He has acted as a technical expert both within and outside Spain in many cases involving blockbuster drugs such as atorvastatin\, escitalopram\, alendronate\, tamsulosine\, venlafaxine and the most recent cases of fulvestrant and pemetrexed. \nBernabé is CEO of ZBM BConnect a consultancy firm that assists private companies and public research institutions when optimizing their technology transfer activities. His main duties in ZBM BC are the management of the company\, obtaining technology from companies and other institutions and conducting negotiations to transfer the technology. \nHe started teaching at the Patent Centre of the University of Barcelona in 1988. He is an expert in searching patent and scientific literature\, as he was a representative of both STN International and Chemical Abstracts Service in Spain for over 10 years. Before this\, he worked for Questel-Orbit. He currently combines his position as partner at ZBM with his position as professor at the University of Barcelona. \nSince 1988 he has lectured regularly on patent matters on courses organised by the Spanish Patent and Trademark Office and the Patent Centre of the University of Barcelona\, as well as on the main Spanish master’s programmes on intellectual property. He has authored several\narticles on patent matters and patent documentation in Spanish newspapers and specialised journals. \nFinally\, Bernabé is vicepresident of Ahead Therapeutics. This start-up biotech company uses a proprietary technology to develop treatments for different autoimmune disorders. \n 
URL:https://creb.upc.edu/event/xartec-salut-training-pill-key-points-to-successfully-protect-your-inventions-by-patents-copyright-and-know-how/
END:VEVENT
END:VCALENDAR